View the PRETOSIS registration information details.
Back to drug list
ItemsDrug Registration information
ID1666
No1666
Brand NamePRETOSIS
IngredientsPRETOMANID 200 MG
Dosage FormTABLET
Primary PackagingBOTTLE
Storage
Shelf Life2 YEARS
Pack Size26 TABLETS/BOTTLE
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsAS PART OF A COMBINATION REGIMEN WITH BEDAQUILINE AND LINEZOLID FOR THE TREATMENT OF ADULT WITH PULMONARY TUBERCULOSIS THAT IS ESISTANT TO ISIONIAZID, RIFAMYCINS, A FLUROQUINOLONE AND A SECOND LINE INJECTABLE ANTIBACTERIAL DRUG OR ADULTS WITH PULMONARY TB RESISTANT TO ISONIAZID AND RIFAMPIN WHO ARE TREATMENT-INTOLERANT OR NONRESPONSIVE TO STANDARD THERAPY.
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionWHITE TABLETS
Note
License OwnerLAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY
ManufacturerLAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY
CountryLAOS
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No03 L 1309/25
FDD Registration Date31/03/2025
Expiry Date30/03/2030
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA